Telehealth-enhanced Hybrid CR for Acute Coronary Syndrome

Columbia University Irving Medical Center, New York, NY
Targeting 2 different conditionsTelehealth-enhanced Hybrid CR +1 moreN/ARecruitingLed by Andrea T Duran, PhDResearch Sponsored by Columbia University

Study Summary

This trial will compare the effects of telehealth-enhanced hybrid cardiac rehabilitation (THCR) versus traditional cardiac rehabilitation (CR) on ACS survivors.

Eligible Conditions
  • Acute Coronary Syndrome
  • Heart Attack


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 3-month post program completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 3-month post program completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean proportion of CR sessions completed by participants allocated to the THCR intervention
Number of participants who are successfully enrolled into the pilot study per month
Secondary outcome measures
Mean proportion of CR sessions completed by those allocated to the traditional CR intervention
Proportion of participants that attend ≥1 CR session after randomization in each arm
Proportion of participants who report adequate feasibility of the THCR intervention
Other outcome measures
Change in health-related quality of life score
Change in total distance traveled in 6MWT

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telehealth-enhanced Hybrid CRExperimental Treatment1 Intervention
Participants will receive a hybrid version of cardiac rehabilitation.
Group II: Traditional CRActive Control1 Intervention
Participants will receive a standard of care version of cardiac rehabilitation.

Find a site

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,381 Previous Clinical Trials
1,836,068 Total Patients Enrolled
9 Trials studying Acute Coronary Syndrome
3,712 Patients Enrolled for Acute Coronary Syndrome
National Institutes of Health (NIH)NIH
2,611 Previous Clinical Trials
6,663,298 Total Patients Enrolled
2 Trials studying Acute Coronary Syndrome
440 Patients Enrolled for Acute Coronary Syndrome
Andrea T Duran, PhDPrincipal Investigator
Columbia University
1 Previous Clinical Trials
4 Total Patients Enrolled
1 Trials studying Acute Coronary Syndrome
4 Patients Enrolled for Acute Coronary Syndrome
Daichi Shimbo, MDStudy Director
Columbia University
2 Previous Clinical Trials
491 Total Patients Enrolled

Media Library

Telehealth-enhanced Hybrid CR Clinical Trial Eligibility Overview. Trial Name: NCT05328375 — N/A
Acute Coronary Syndrome Research Study Groups: Traditional CR, Telehealth-enhanced Hybrid CR
Acute Coronary Syndrome Clinical Trial 2023: Telehealth-enhanced Hybrid CR Highlights & Side Effects. Trial Name: NCT05328375 — N/A
Telehealth-enhanced Hybrid CR 2023 Treatment Timeline for Medical Study. Trial Name: NCT05328375 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of enrollment for this clinical research study?

"Affirmative. The information found at verifies that this trial is still open to new participants, having been first published on March 11th 2022 and last updated in May 4th 2022. 40 individuals are needed from 1 location for the study's completion."

Answered by AI

Are investigators currently enrolling participants in this investigation?

"The information on reveals that this scientific endeavor is actively recruiting volunteers. It was originally launched on March 11th 2022 and the latest update to its profile occurred on May 4th 2022."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Columbia University Irving Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
~16 spots leftby Oct 2024